Parexel has launched its Regulatory & Access consulting organization designed to optimize clinical development from the earliest stages. The newly formed Regulatory & Access team includes more than 1,000 on-staff consultants worldwide, including 100 former regulators and HTA assessors, to help navigate development and bring new therapies to patients. “Today, achieving market authorization from a regulatory agency is only the first hurdle to a new therapy reaching the market,” said Pa...